BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 18408447)

  • 41. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
    Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
    Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Age and CD20 Expression Are Significant Prognostic Factors in Human Herpes Virus-8-negative Effusion-based Lymphoma.
    Kubota T; Sasaki Y; Shiozawa E; Takimoto M; Hishima T; Chong JM
    Am J Surg Pathol; 2018 Dec; 42(12):1607-1616. PubMed ID: 30273194
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intracavitary cidofovir for human herpes virus-8-associated primary effusion lymphoma in an HIV-negative patient.
    Stingaciu S; Ticchioni M; Sudaka I; Haudebourg J; Mounier N
    Clin Adv Hematol Oncol; 2010 May; 8(5):367-74. PubMed ID: 20551896
    [No Abstract]   [Full Text] [Related]  

  • 44. Primary Effusion Lymphoma: Cytological Diagnosis of a Rare Entity--Report of Two Cases in HIV-Uninfected Patients from a Single Institution.
    Nicola M; Onorati M; Bianchi CL; Pepe G; Bellone S; Di Nuovo F
    Acta Cytol; 2015; 59(5):425-8. PubMed ID: 26658724
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Primary effusion lymphoma of the pleural space: Report of a rare complication of cardiac transplant with review of the literature.
    Kugasia IAR; Kumar A; Khatri A; Saeed F; Islam H; Epelbaum O
    Transpl Infect Dis; 2019 Feb; 21(1):e13005. PubMed ID: 30276937
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Kaposi sarcoma herpesvirus/human herpesvirus-8-negative effusion-based lymphoma: report of 3 cases and review of the literature.
    Xiao J; Selvaggi SM; Leith CP; Fitzgerald SA; Stewart J
    Cancer Cytopathol; 2013 Nov; 121(11):661-9. PubMed ID: 23765802
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic significance of maximum tumour (bulk) diameter in young patients with good-prognosis diffuse large-B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: an exploratory analysis of the MabThera International Trial Group (MInT) study.
    Pfreundschuh M; Ho AD; Cavallin-Stahl E; Wolf M; Pettengell R; Vasova I; Belch A; Walewski J; Zinzani PL; Mingrone W; Kvaloy S; Shpilberg O; Jaeger U; Hansen M; Corrado C; Scheliga A; Loeffler M; Kuhnt E;
    Lancet Oncol; 2008 May; 9(5):435-44. PubMed ID: 18400558
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Burkitt post-transplantation lymphoma in adult solid organ transplant recipients: sequential immunochemotherapy with rituximab (R) followed by cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or R-CHOP is safe and effective in an analysis of 8 patients.
    Zimmermann H; Reinke P; Neuhaus R; Lehmkuhl H; Oertel S; Atta J; Planker M; Gärtner B; Lenze D; Anagnostopoulos I; Riess H; Trappe RU
    Cancer; 2012 Oct; 118(19):4715-24. PubMed ID: 22392525
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Remission of an HHV8-related extracavitary primary effusion lymphoma in an HIV-positive patient during antiretroviral treatment containing dolutegravir.
    Campogiani L; Cerva C; Maffongelli G; Teti E; Pupo L; Vaccarini S; Cantonetti M; Pennica A; Andreoni M; Sarmati L
    AIDS Res Ther; 2019 Jul; 16(1):15. PubMed ID: 31351487
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Brief-duration rituximab/chemotherapy followed by maintenance rituximab in patients with diffuse large B-cell lymphoma who are poor candidates for R-CHOP chemotherapy: a phase II trial of the Sarah Cannon Oncology Research Consortium.
    Hainsworth JD; Flinn IW; Spigel DR; Clark BL; Griner PL; Vazquez ER; Doss HH; Shipley D; Franco LA; Burris HA; Greco FA;
    Clin Lymphoma Myeloma Leuk; 2010 Feb; 10(1):44-50. PubMed ID: 20223728
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Extracavitary/solid variant of primary effusion lymphoma.
    Kim Y; Leventaki V; Bhaijee F; Jackson CC; Medeiros LJ; Vega F
    Ann Diagn Pathol; 2012 Dec; 16(6):441-6. PubMed ID: 22497739
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cytologic diagnosis of primary effusion lymphoma in an HIV-negative patient.
    Su YC; Chai CY; Chuang SS; Liao YL; Kang WY
    Kaohsiung J Med Sci; 2008 Oct; 24(10):548-52. PubMed ID: 19181587
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Complete remission and virologic response to combined chemoimmunotherapy (R-CVP) followed by rituximab maintenance in HIV-negative, HHV-8 positive patient with multicentric Castleman disease.
    Fragasso A; Mannarella C; Ciancio A; Calvario A; Scarasciulli ML
    Leuk Lymphoma; 2008 Nov; 49(11):2224-6. PubMed ID: 19021070
    [No Abstract]   [Full Text] [Related]  

  • 54. Extracavitary/solid variant of primary effusion lymphoma presenting as a gastric mass.
    Liao G; Cai J; Yue C; Qing X
    Exp Mol Pathol; 2015 Dec; 99(3):445-8. PubMed ID: 26407759
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Optimization of rituximab for the treatment of diffuse large B-cell lymphoma (II): extended rituximab exposure time in the SMARTE-R-CHOP-14 trial of the german high-grade non-Hodgkin lymphoma study group.
    Pfreundschuh M; Poeschel V; Zeynalova S; Hänel M; Held G; Schmitz N; Viardot A; Dreyling MH; Hallek M; Mueller C; Wiesen MH; Witzens-Harig M; Truemper L; Keller U; Rixecker T; Zwick C; Murawski N
    J Clin Oncol; 2014 Dec; 32(36):4127-33. PubMed ID: 25403207
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [A five year follow-up of an HHV-8 related lymphoma in an HIV-negative elderly patient].
    Danese C; Angrisani L; Colotto M; Clarice A; Ferranti E
    Clin Ter; 2004; 155(11-12):543-6. PubMed ID: 15861969
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recurrent pericardial effusion after treatment for primary effusion lymphoma-like lymphoma: an autopsied case.
    Kagoya Y; Takahashi T; Yoshimoto T; Ichikawa M; Hangaishi A; Fukayama M; Kurokawa M
    Ann Hematol; 2011 Feb; 90(2):219-20. PubMed ID: 20432036
    [No Abstract]   [Full Text] [Related]  

  • 58. Management and Outcomes of HIV-Associated Primary Effusion Lymphoma: A Single Center Experience.
    Gupta A; Sen S; Marley E; Chen W; Naina HV
    Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S175-80. PubMed ID: 27521315
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rituximab combined with MACOP-B or VACOP-B and radiation therapy in primary mediastinal large B-cell lymphoma: a retrospective study.
    Zinzani PL; Stefoni V; Finolezzi E; Brusamolino E; Cabras MG; Chiappella A; Salvi F; Rossi A; Broccoli A; Martelli M
    Clin Lymphoma Myeloma; 2009 Oct; 9(5):381-5. PubMed ID: 19858058
    [TBL] [Abstract][Full Text] [Related]  

  • 60. HIV-associated primary effusion lymphoma presenting as a paracardial mass.
    Katz H; Rose C; Rivera NT; Bray N
    BMJ Case Rep; 2015 Feb; 2015():. PubMed ID: 25725030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.